Peripheral Vascular Stents Market Analysis

Segmentation Analysis:

In terms of segmentation, the global Peripheral Vascular Stents market is analyzed on the basis of Type, Mode Of Delivery, Product, End-Use.

Peripheral Vascular Stents Market:

Drug Eluting Stents:

The drug eluting stents segment of the peripheral vascular stents market is expected to witness significant growth during the forecast period. These stents are coated with medications that help prevent restenosis and reduce the need for repeat procedures. The growing prevalence of vascular diseases and the increasing adoption of minimally invasive procedures are driving the demand for drug eluting stents in the market.

Bare Metal Stents:

The bare metal stents segment is also projected to experience steady growth in the peripheral vascular stents market. These stents are made of metal alloys such as stainless steel and cobalt-chromium, providing structural support to the blocked or narrowed arteries. The cost-effectiveness and ease of use of bare metal stents make them a popular choice among healthcare providers and patients.

Bioabsorbable Stents:

Bioabsorbable stents are gaining traction in the peripheral vascular stents market due to their ability to dissolve over time, eliminating the need for long-term medication and reducing the risk of late stent thrombosis. The segment is expected to witness rapid growth with advancements in technology and increasing awareness among patients about the benefits of bioabsorbable stents.

Mode of Delivery:

The mode of delivery of peripheral vascular stents, including balloon-expandable stents, self-expandable stents, and balloon catheters, plays a crucial role in determining the success of the procedure. Healthcare providers are increasingly opting for self-expandable stents due to their flexibility and ease of deployment, leading to the growth of this segment in the market.

Product:

The peripheral vascular stents market offers a wide range of products, including coronary stents, iliac stents, femoral stents, renal stents, and carotid stents. The increasing prevalence of peripheral vascular diseases and the rising geriatric population are driving the demand for these products in the market. Coronary stents are the most commonly used product in the peripheral vascular stents market, owing to the high incidence of coronary artery diseases.

End-use:

Hospitals, ambulatory surgical centers, and specialty clinics are the key end-users of peripheral vascular stents. Hospitals account for the largest share of the market due to the availability of advanced infrastructure and skilled healthcare professionals. Ambulatory surgical centers are gaining popularity among patients for minimally invasive procedures, boosting the demand for peripheral vascular stents in this segment. Specialty clinics cater to patients with specific vascular conditions, further driving the market growth.